PMGC Holdings Inc. (ELAB) vs TransCode Therapeutics, Inc. (RNAZ)
A side-by-side comparison of PMGC Holdings Inc. and TransCode Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ELAB
PMGC Holdings Inc.
$3.24HealthcareDelayed quote: Oct 6, 2026, 2:31 PM EDT
RNAZ
TransCode Therapeutics, Inc.
$1.73HealthcareDelayed quote: Oct 6, 2026, 2:42 PM EDT
Total return — ELAB vs RNAZ
growth of $100 · dividends reinvested · last 3yELAB -100.0% (-99.4%/yr)RNAZ -100.0% (-93.3%/yr)RNAZ compounded faster over this window
Log scale — wide-divergence pair
ELAB RNAZ
ELAB vs RNAZ: by the numbers
- •RNAZ is the larger company ($2M vs $1M market cap).
- •Both run net losses; RNAZ's is the smaller (0.00% vs -522.97% net margin).
Metrics side by side
Valuation
| Metric | ELAB | RNAZ |
|---|---|---|
| P/S ratio | 0.57 | N/A |
| P/B ratio | 0.09 | N/A |
Profitability
| Metric | ELAB | RNAZ |
|---|---|---|
| Gross margin | 10.31% | 0.00% |
| Operating margin | -1250.11% | 0.00% |
| Net margin | -522.97% | 0.00% |
| ROE | -80.57% | -30.92% |
| ROIC | N/A | -23.73% |
Growth (annualized)
| Metric | ELAB | RNAZ |
|---|---|---|
| Total return CAGR (5Y) | N/A | -93.39% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.